News
Sirius Medical and RMS Medical Devices announce commercial partnership for Belgium and Luxemburg
Sirius Medical, a medical device innovator developing the next generation of tumor localization technology, is pleased to announce today that RMS Medical Devices will be commercial partner in Belgium and Luxemburg for Sirius Pintuition.
Incircular raises €300.000 for the development of their INCRYTPO technology
Venture Challenge alumnus Incircular has received a convertible loan of € 300,000 from the Innovation Fund Noord-Holland for the development of its INCYPRO technology to stabilise proteins for pharmaceutical and diagnostic applications.
VFF awarded to Venture Challenge winner SLAM Ortho
Venture Challenge Winner SLAM Orthopedic has been awarded the Vroegefasefinanciering (VFF) by the Rijksdienst voor Ondernemend Nederland (RVO)
Drug-disposition-on-a-chip: A European public private consortium to better predict the behaviour of drugs in humans by networked mini-organs.
Venture Challenge alumnus Cell4Phamra is excited to announce their involvement in the public-private consortium to develop a four organ on a chip model. Organ-on-chip technology has allowed researchers to study physiological systems in vitro
Prolira signs collaboration with Orion Pharma for sales of DeltaScan in Germany
The companies ORION Pharma and Prolira are excited to announce their sales collaboration agreement that has been signed in June 2021.
Venture Challenge Summer 2021: Meet the Teams!
Last week, the Venture Challenge Summer 2021 kicked off with innovative Life Sciences & Health startups participating in the first bootcamp. The participating teams worked on shaping their value propositions, vision and competitive differentiation to translate their idea into a solid business case.
Venture Challenge alumnus Prolira successfully completes DeltaStudy
UMC Utrecht carried out an investigator initiated large scale validation study for DeltaScan device performance, collecting data from a wide study population of 434 hospitalized patients, spread over 9 Dutch hospitals and 31 departments.
Nutrileads appoints Erik Dam as CEO to propel the company towards successful commercialization of its lead ingredient BeniCaros
Dutch health ingredients innovator, NutriLeads, announces the appointment of Erik Dam as CEO to lead the company’s transition from a health ingredients innovator to a commercial health ingredients company based on a strong science foundation.
Venture Challenge alumnus Scope wins AtlasInvest Start-Up Award
Scope Biosciences was announced as one of the two winners of the AtlasInvest Entrepreneurship Grant during the F&A Next
Want to further develop your business skills? Then register for the TAP BioBusiness training programme
Are you a future BioBusiness leader in Life Sciences & Health? Register now for the TAP BioBusiness training programme and benefit from the early bird fee until 1 June 2021!